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A B S T R A C T
Oct4 is involved in regulation of pluripotency during normal development and is down-regulated during
formation of postnatal reservoir of germ cells. We propose thatOct4/GFP transgenic mouse, which
mimics the endogenous expression pattern of Oct4, could be used as a mammalian model to study the
effects of environmental estrogens on the development of male germ cells. Oct4/GFP maturation proﬁle
was assessed during postnatal days -PND- 3, 5, 7, 10, 14 and 80, using ﬂow cytometry. Then, we exposed
pregnant mothers to 17a-ethinylestradiol (EE2) from day post coitum (dpc) 5 to PND7. Percentage of
Oct4/GFP-expressing cells and levels of expression of Oct4/GPF were increased in PND7 after EE2
exposure. These observations were conﬁrmed by analysis of GFP and endogenous Oct4 protein in the
seminiferous tubules and by a reduction in epididymal sperm count in adult mice. We introduced Oct4/
GFP mouse together with ﬂow cytometry as a tool to evaluate changes in male germ cells development.
ã 2015 Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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journal homepage: www.else vie r .com/locate / j sbmb1. Introduction
Spermatogenesis is a stem cell–dependent process supported
by self-renewal and differentiation of spermatogonial stem
cells (SSCs). During fetal testicular development, germ cells
undergo different maturation processes to become SSCs at birth.
Primordial germ cells ﬁrst appear in the mouse embryo on
embryonic day (E) 6.5, and then, from E6.5–E10.5, proliferate and
migrate towards the genital ridges, where they become enclosed
by the differentiating Sertoli cells. Testicular cords are then
formed in males. The germ cells present within the testicular
cords mature into gonocytes, which proliferate for a few days
followed by a mitotic arrest at the G1/G0 phase. During the ﬁrst
week after birth, gonocytes resume proliferation and relocate
from their original central position in the seminiferous tubules
toward the basement membrane and differentiate into* Corresponding author.
E-mail address: harodrig@fbcb.unl.edu.ar (H.A. Rodríguez).
1 These authors equally contributed to this work.
http://dx.doi.org/10.1016/j.jsbmb.2015.06.006
0960-0760/ã 2015 Elsevier Ltd. All rights reserved.spermatogonia between postnatal day (PND) 3 and PND6. These
nascent spermatogonial cells have primitive morphological
features similar to type A spermatogonia in adults [1–2]. SSCs
are a subpopulation of the reservoir of undifferentiated sper-
matogonia residing in the basal layer of the seminiferous
epithelium [3]. Concurrently, epigenetic changes and differential
expression of pluripotency genes occur during development of
male germ cells. Among the core genes associated with
pluripotency is Oct4, a member of the class V Pic-1 Oct1,2
Unc-86 (POU) transcription factors. Oct4 is expressed in
proliferating gonocytes during the embryonic stage and in
undifferentiated spermatogoniaafter birth [4,5]. As spermatogen-
esis starts, Oct4 expression continues in undifferentiated type A
spermatogonia and is down-regulated as germ cells begin
spermatogenic maturation (4). Oct4 plays an important role in
the establishment and maintenance of the stem cell pluripotency;
a precise level of Oct4 is required to sustain stem cell self-renewal
and Oct4 also governs distinct fates of stem cells [6,7]. In addition,
Oct4 is required to maintain SSCs in an undifferentiated state and
therefore to maintain their self-renewal in both cultured and
transplanted testes [8,9].
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the developing testis both at the prenatal and postnatal stages
[10,11]. It has been shown that 17b-estradiol induces the
proliferation of neonatal testicular gonocytes and spermatogonia
in vitro, suggesting that it may act as the physiological regulator of
gonocyte development in vivo [12,13]. Sinkevicius and colleagues
showed that estrogen-dependent ER a signaling is required for
germ cell viability, most likely through support of Sertoli cell
function. They also provided strong evidence suggesting that
neonatal estrogen signaling is required for the development of
normal adult fertility rates [14]. Disruption of the hormonal
microenvironment during gonad differentiation could result in
developmental deﬁciencies and health problems later in life,
including cryptorchidism, hypospadias, decreased spermatogene-
sis, hypogonadism and testicular germ cell cancer [15–17]. In vivo
exposure to increased 17b-estradiol concentrations causes pre-
mature sperm capacitation in the epididymis with a potential
negative impact on the sperm reproductive ﬁtness in the female
reproductive tract [18]. Several studies link male reproductive
disorders to the disruption of the early testis development
by endocrine-disrupting chemicals (EDCs) [15,19]. Germ cell
sloughing, disruption of the blood–testis barrier and germ cell
apoptosis have been reported after environmental exposure to
exogenous estrogenic compounds during early childhood devel-
opment [20,21]. In addition, transgenerational epigenetic effects
on male reproduction may increase the potential impact of
environmental toxins [21].
As mentioned above, Oct4 localizes in proliferating gonocytes
and after birth in undifferentiated A spermatogonia [4,9]. It is thus
used as a marker of SSCs (9). Based on this property, an Oct4-GFP
transgenic mice that mimics the endogenous expression pattern of
Oct4 in the prenatal and early postnatal period was developed, in
which Oct4-expressing germ cells can be identiﬁed at various
developmental stages [22,23].
In the last years, ﬂow cytometry has demonstrated to be a
powerful and versatile tool to study diverse biological problems.
A major advantage of this technique is its ability to provide
quantitative relevant information even from rare events, making
it possible to analyze statistically small cell populations. Herein,
we characterize the expression pattern of Oct4-GFP in this
transgenic mouse through the postnatal and adult stages of male
germ cells maturation, using ﬂow cytometry as the main analysis
tool. We identiﬁed and optimized various parameters to evaluate
male germ cells development by Oct4/GFP expression. In
addition, we assessed whether this transgenic mouse model
would be suitable to identify the changes caused by exposure to
ethinylestradiol (EE2) on Oct4/GFP expression associated to
reservoir formation of male germ cells. Our results showed
that the transgenic Oct4/GFP mouse together with ﬂow cytometry
is a suitable tool to evaluate changes in male germ cells
development and they could be used to identify early life
exposures to EDCs.
2. Material and methods
2.1. Animals
C57BL/6 Oct4/GFP transgenic mice were a kind gift from Dr.
Konstantinos Anastassiadis, Biotec Technische Universität
Dresden, Germany [24]. Animals were bred under speciﬁc
pathogen-free conditions at the animal facility of the
Transgenic and Experimental Animal Unit of Institut Pasteur de
Montevideo, Uruguay (IPMon). Mice were housed in individual
ventilated cages with positive pressure, at 20  1 C, relative
humidity of 40–60% and a 14/10 light–dark cycle. Animals were
fed with standard mouse diet ad libitum and had free access towater during the experimental protocol. All animal procedures
were approved by the Animal Care Committee of the IPMon
and in accordance with national law N 18.611 and international
guidelines of the Federation of Laboratory Animal Science
Associations (FELASA) regarding laboratory animal protocols.
2.2. Genomic DNA isolation and genotyping of Oct4/GFP transgene
Mouse tails were immersed in 0.5 mL lysis buffer (10 mMTris,
100 mMNaCl, 0.5% SDS and 0.5 mg/mL Proteinase K) and
incubated overnight at 37 C. After incubation, proteins were
precipitated with the addition of 0.3 mL of 5 MNaCl and
incubated for 10 min on ice. Samples were centrifuged 10 min
at 9000  g and the supernatant was transferred to a new tube
containing 0.8 mL of glacial ethanol at room temperature (RT).
Samples were centrifuged for 10 min at 14,000  g and the
DNA pellet was recovered and washed twice with 0.5 mL of 70%
ethanol. Finally, the DNA pellet was dried at RT and resuspended in
0.03 mL of MilliQ water. Oct4/GFP mice were genotyped by
polymerase chain reaction (PCR), using speciﬁc primers: 50-CTT
CTT CAA GGA CGA CGG CAA CTA-30 (forward) and 50-ATC GCG CTT
CTC GTT GGG GTC TTT-30 (reverse) for eGFP gene detection.
Mammalian enabled (Mena) was used as housekeeping gene: 50-
CAG CAG ACT GAG GGG ACA G-30 (forward) and 50-GGCAGGACTT-
GAATCTGGAG-30 (reverse). The PCR conditions for both eGFP and
Mena were as follows: 4 min at 94 C; 35 cycles (45 sec 94 C; 1 min
55 C; 1 min 72 C), a ﬁnal extension of 10 min at 72 C and 10 min
at 4 C.
2.3. Cell preparation
To establish the postnatal Oct4/GFP expression proﬁle, testes
were collected from animals at 3 (n = 5), 5 (n = 4), 7 (n = 8), 10
(n = 8), 14 (n = 6) days of age and at the adult stage (80 days old).
Male mice were killed by decapitation (pups) or carbon dioxide
inhalation (adults). Both testes for the pups or one testis for
the adult animal were isolated (the tunica albuginea removed) and
placed into a 12-well culture plate with 0.5 mL PBS-EDTA
supplemented with 2% bovine serum albumin (BSA). The genotype
was determined by ﬂuorescence microscopy (Olympus IX81) of
the whole testis, and further conﬁrmed by PCR analysis as
described previously. Decapsulated testes from pups were
centrifuged at 300  g for 5 min, the supernatant was discarded
and the pellet was resuspended in 1 mL collagenase Type II
(1 mg/mL, C6885, Sigma, St Louis, MO, USA) and incubated
at 32–35 C for 15 min. The cell suspension was agitated every
5 min to dissociate the seminiferous tubules and to release
interstitial cells. After incubation, the cell suspension was
centrifuged for 5 min at 300  g at RT and the supernatant was
discarded. The remaining cells were washed with 1 mL PBS-EDTA-
2% BSA. After centrifugation for 5 min at RT, the supernatant was
discarded and cells were resuspended in 0.8 mL of 0.05% trypsin-
EDTA and incubated for 10 min at 32–35 C, agitating every 5 min.
Enzyme activity was blocked by addition of 0.2 mL fetal bovine
serum (FBS, GIBCO, Grand Island, NY, USA). After centrifugation,
cells were resuspended in 1 mL of Dulbecco’s Modiﬁed Eagle
Medium (DMEM), (Invitrogen, CA, USA) supplemented with 10 %
FBS and further dissociated by pipetting up and down several
times. To obtain the cell suspension from adult testes, the
collagenase treatment was avoided, proceeding directly to the
incubation with trypsin.
The testicular cell suspension was ﬁxed by incubation with
4% paraformaldehyde for 0.5–2 h, centrifuged, resuspended in
PBS-EDTA-2% BSA and ﬁltered through a 50 mm pore size Nylon
mesh. The resultant single cell suspension was used for ﬂow
cytometry analysis.
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Flow cytometry analysis was performed in a CyAnTMADP
analyzer (Beckman Coulter Inc., IN, USA) equipped with 488 nm
and 635 nm lasers. Data was acquired with Summit v4.3 (Beckman
Coulter Inc., IN, USA) and postacquisition analysis was performed
using FlowJo vX.0.7 (Tree Star Inc, Ashland, OR, USA) software. For
each sample, the following parameters were studied: forward
scatter versus side scatter to deﬁne the acquisition gates for intact
cells, forward scatter versus Pulse Width dot plot for doublet
discrimination and side scatter versus FL1 channel (530/40 band
pass) dot plot for GFP detection. A minimum of 10,000 single intact
cells were collected for analysis in each sample.
To study Oct4 expression by GFP ﬂuorescence, three parameters
were deﬁned using side scatter versus FL1 channel dot plot and FL1
channel histogram: (1) the percentage of Oct4/GFP positive cells, as
an indicator of the number of immature cells in the gonads; (2) the
increase in the mean ﬂuorescence intensity (MFIi), as an indicator
of the maturation of the cells; (3) the percentage of Oct4/GFP
positive cells with bright (Oct4+ bright) and dim (Oct4+ dim)
ﬂuorescence intensity.
The MFIi was deﬁned as the difference between the Mean
Fluorescence Intensity (MFI) of the GFPpositive and GFP negative
cell fraction divided by the MFI of the negative fraction of each
sample, as follows:
MFLi ¼ ðMFLI GFP
þ  MFLI GFPÞ
MFLI GFP
Distinct positive populations expressing different amounts of
GFP were detected, thus, the percentage of Oct4+ dim and Oct4+
bright cells were calculated considering the log decades in the FL1
ﬂuorescence channel (from 101–102 and 102 –103, for dim and
bright, respectively).
2.5. Oral administration of EE2
To assess the effect of estrogens in the development of male
germ cells during the perinatal period, female pregnant mice were
exposed to EE2 (Sigma, St Louis, MO, USA). Changes in cell
maturation were evaluated in the offspring by the Oct4 ﬂow
cytometric expression proﬁle, using the same parameters de-
scribed previously. Six- to eight-week-old Oct4/GFP mice were
mated. Females with a copulation plug (dpc 0.5) were randomly
separated in two groups: EE2 5 mg/kg of body weight,and Ethanol
(0.1 %) as the vehicle control group. The dose of 5ug/kg.day has
been referred as the appropriate dose that must be assayed to
demonstrate the sensitivity to estrogenic action of the endpoint of
interest in an animal model when chemicals are administered
orally [25]. Both compounds were administered daily by oral
gavage from dpc5.5 to PND7, in a single dose using a maximum
volume of 0.2 mL. The male offspring of the treated females (n = 10
for EE2, and n = 11 for the vehicle control group) were sacriﬁced on
PND7 and the testicular cell suspensions were analyzed by ﬂow
cytometry.
2.6. Immunohistochemistry
In control and EE2-treated males, testes from PND7 male mice
(n = 11 and n = 10, respectively) were assigned to GFP and Oct4
protein detection by immunohistochemical staining. Testes were
isolated and ﬁxed in 4% PFA for 2 h at RT and embedded in parafﬁn.
At least three sections (5 mm thickness) at different depths from
each testis were immunostained as previously described [26].
After deparafﬁnization, microwave pretreatment (antigen retriev-
al) was performed. GFP (A10260, Invitrogen, CA, USA) and Oct4(sc5279, Santa CruzBiotechnology, CA, USA) antibodies were
incubated overnight at 4 C (GFP: 0.2 mg/mL; Oct4: 0.04 mg/mL).
Biotinylated anti-rabbit IgG and anti-mouse IgG (Sigma–Aldrich
Argentina S.A., Buenos Aires, Argentina) were used as secondary
antibodies, respectively. Reactions were developed by the
streptavidin–biotin peroxidase labeling method, which uses
diaminobenzidine (DAB) (Sigma–AldrichArgentina) as a chromo-
gen substrate. Samples were counterstained with Mayer hematox-
ylin (Biopur, Rosario, Argentina) and mounted with permanent
mounting medium (PMyR, Buenos Aires, Argentina). For negative
controls, the primary antibody was replaced with non-immune
mouse or rabbit serum (Sigma).
2.7. Sperm count, viability and motility of adult male mice treated
perinatally with EE2
Adult male mice (PND 130) from control (n = 4) and EE2 (n = 4)
groups were sacriﬁced by cervical dislocation. The left cauda
epididymis were removed, cut three times with dissecting scissors
and put in a 1.5 mL eppendorf with 1 mL of Phosphate-Buffered
Saline (PBS). The tissues were incubated for 10 min at 37 C to
release the sperm.
Sperm count and viability were carried out using ﬂow
cytometry. Viability was evaluated with propidium iodide (PI)
staining. This compound is excluded by viable cells but can
penetrate cell membranes of dying or dead cells. Sperm count was
assayed at the same time, using ﬂuorescence beads (CountBrightTM
Absolute Counting Beads; Life).
Sperm suspension was diluted 1:10 and stained with PI (ﬁnal
concentration 2 ug/mL) and mixed with 3000 ﬂuorescence beads
in a ﬁnal volume of 300uL of PBS. For each duplicate sample, 1000
beads were counted using a gate on an SSC versus FL1 dot plot. The
total sperm count per epididymis was calculated using the
formula:
cells per epididymis ¼ 100  average count sperm
Sperm motility was assessed within thirty minutes after
epididymis removal to limit the deleterious effects of dehydration,
pH or changes in temperature on motility. Two hundred whole
spermatozoon (head and tail) were analyzed in duplicate per
animal using an optic microscopy at 400  magniﬁcation. Sperma-
tozoa were classiﬁed according to three types of motility:
Progressive motility (PR): spermatozoa moving actively, either
linearly or in a large circle, regardless of speed. Non-progressive
motility (NP): all other patterns of motility with an absence of
progression. Immotility (IM): no movement.
2.8. Statistical analysis
Data was analyzed using the GraphPad Prismã software version
5.0 (San Diego, USA) and results are presented as the mean  SEM.
One-way ANOVA was conducted to analyze differences in the
percentage of Oct4/GFP positive cells, Oct4+ dim and Oct4+bright
fractions, MFIi and sex ratio at different ages. Bonferroni’s multiple
comparison test was performed when appropriate. The non-
parametric Mann Whitney test was used to analyze the effects of
EE2 treatment using the above-mentioned parameters. Levels of
signiﬁcance were set at p  0.05.
3. Results
In the present study, we propose the Oct4/GFP transgenic
mouse as a new mammalian model to study the effects of perinatal
exposure to environmental estrogens on male germ cell
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newborn or treatment. The litter size was between 5 and 6 puppies.
The average male/female ratio was 47.9  10.5 % and 52.1 10.5 %
males and females, respectively. There were no signiﬁcant
differences between groups (ANOVA, p = 0.17). Flow cytometry
was selected as the main analyzing tool. In order to characterize
the germinal maturation proﬁle in this mouse model, we
optimized and assessed the following parameters during pre-
pubertal (PND3 to PND14) and adult age: 1) the percentage of Oct4/
GFP-expressing cells; 2) the MFIi of Oct4/GFP-positive cells and 3)
the percentage of Oct4+ bright and dim cells. Fig. 1 shows an
example of how those parameters were established.
Moreover, the model was challenged by exposing pregnant
females to EE2 from dpc 5.5 to PND7. The alteration of germ cell
maturation by estrogenic exposure during perinatal period was
evaluated by the Oct4/GFP ﬂow cytometry proﬁles and later in life,
in adult male offspring, by analyzing sperm parameters, as
described in section 3.4.
3.1. Proportion of Oct4/GFPpositive cells during gonad maturation
The proportion of immature germ cells at the pre-pubertal
stage was studied from mouse specimens at PND3, 5, 7, 10, 14 and
adulthood (Fig. 2). Fig. 3 shows that the proportion of Oct4/GFP
positive cells was 3.98  0.25% at PND3 and then showed a
signiﬁcant increase during the maturation of the gonad
from 5.22  0.42% at PND5 to 14.66  0.59% at PND7 (ANOVA:
p < 0.0001). The proportion of Oct4/GFPpositive cells then
decreased at PND10, showing two subpopulations within the
same group of animals: some displayed slower gonad maturation,
evidenced by a high proportion of Oct4/GFPpositive cells
(14.75 1.06%), while others displayed a decrease (2.60  1.00%).
The same behavior was still observed at PND14, with a subgroup of
mice maintaining a high percentage of Oct4/GFPpositive cells
(10.9  0.14%) and the other subgroup having a low proportion of
these cells (2.95 1.52%). By PND80 (adult mice), the proportion of
these cells remained below 1% (data not shown).
3.2. Oct4/GFP expression level during gonad maturation
The expression level of the Oct4 gene in the immature germ cell
population was assessed by two selected parameters: the MFIi ofFig. 1. Flow cytometry analysis of testicular cell suspension evaluating Oct4 expressio
ﬂuorescent intensity of the GFP negative (light blue) and positive (pink) cell fraction an
bright (purple) cells. (For interpretation of the references to color in this ﬁgure legendOct4/GFP and the percentage of Oct4+ bright cells (which reﬂects
the most undifferentiated spermatogonia cells). As shown in Fig. 4,
the MFIi was highest at PND3 (34.23  6.13) and then decreased
signiﬁcantly at PND5 (ANOVA: p < 0.0001), reaching 12.37  1.09.
These levels remained unchanged at PND7, 10 and 14 (8.23 1.17;
10.77  1.01 and 6.17  0.47, respectively). When analyzing the
proportion of Oct4+ bright and dim cells (Fig. 5), we observed that
at PND3 the highest proportion of Oct4/GFPpositive cells showed
strong GFP expression, with 61.28  7.53% for Oct4+ bright cells and
35.90  6.48 % for Oct4+ dim cells. This pattern was reversed at
PND5, and remained so until PND14 (between 12.25 and 22.73% for
Oct4+ bright cells).
3.3. Oct4/GFP expression proﬁle after EE2 prenatal exposure
To validate the transgenic C57BL/6 Oct4/GFP mouse model to
evaluate the effect of perinatal estrogen exposure during the
development of germ cells, pregnant females were treated with
EE2 or vehicle from dpc 5.5 to PND7. The offspring were euthanized
at PND7 and testicular cell suspensions were subjected to ﬂow
cytometry analysis using the above-described parameters. As
shown in Fig. 6, the percentage of Oct4/GFP expressing cells was
signiﬁcantly increased after EE2 exposure (Mann Whitney test
p < 0.0048). Similarly, the MFIi for Oct4/GFP-positive cells was
signiﬁcantly incremented in the treated group (Mann Whitney test
p < 0.0011) together with the proportion of Oct4+ bright cells
(Mann Whitney test p < 0.0067).
To conﬁrm whether the changes observed in Oct4/GFP
cytometry proﬁles occur in parallel with changes in protein
expression levels of Oct4 and GFP in the seminiferous tubules,
immunohistochemical analysis of both proteins was performed in
testes of 7-day-old pups treated with vehicle or EE2. Fig. 7 shows
that both GFP and endogenous Oct4 were expressed in the
seminiferous epithelium. The distribution within the seminiferous
tubules correlated with the morphology and pattern of tissue
expression previously described for Oct4 in newborn male mice at
the same age, suggesting that both appear to be conﬁned to the
type Aspermatogonia population [7]. Additionally, both GFP and
Oct4 protein expression showed increased levels in seminiferous
tubules from EE2-treated mice compared to vehicle-treated
animals (Fig. 7); this ﬁnding correlates with the ﬂow cytometry
data indicating increased number of Oct4/GFP positive cells.n: A) percentage of Oct4/GFP positive cells, B) Oct4/GFP histogram showing the
d C) Oct4/GFP+ histogram illustrating the proportion of Oct4+ dim (pink) and Oct4+
, the reader is referred to the web version of this article.)
Fig. 2. Representative pseudocolordot plots of Oct4/GFP positive cells proﬁle throughout prepubertal stages (A, B, C, D and E: PND3, 5, 7, 10 and 14, respectively) and
adulthood (F: PND80) in male mice. Red dots indicate high density while the blue ones denote low density. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)
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perinatal exposure
In order to evaluate if the perinatal treatment with EE2 induced
adverse effects in adulthood, sperm count, viability and motility
were analyzed in adult male mice.
Although there was no differences in sperm motility and
viability, the number of spermatozoa per epididymis (Fig. 8) was
signiﬁcantly reduced in animals treated with EE2 (expressed in
millions of spermatozoa per epididymis, Control = 7.87  0.83;
EE2 = 4.40  0.23).Fig. 3. Percentage of Oct4/GFP positive cells during prepubertal stages of the male
gonad. A signiﬁcant increase of these cells was observed at PND7 (Anova:
p < 0.0001).4. Discussion / Conclusion
Understanding the effects of environmental estrogens on germ
cell differentiation is an area of growing interest in the ﬁeld of
endocrine disruption [27]. Herein, we propose that transgenic
Oct4-GFP mouse could be a good mammalian model to study the
effects of perinatal exposure to environmental estrogens on the
development of male germ cells. We demonstrated the utility of
this animal model to quantitatively assess early in life the
alterations in germ cell differentiation caused by exposure to a
low dose of EE2, a synthetic estrogen which is also considered anFig. 4. MFIi of Oct4/GFP positive cells during prepubertal stages of the male gonad.
Signiﬁcant differences were observed through the maturation process (Anova:
p < 0.0001). The highest increment was observed at PND3 with a signiﬁcant
decrease at PND5 (Bonferroni test p < 0.05) maintaining these levels throughout
PND7, 10 and 14. Letter a indicates statistical difference from b.
Fig. 5. Proportion of Oct4+ bright (black) and dim (white) cells during prepubertal
stages of the male gonad maturation (total Oct4+ cells were considered 100%). Oct4
+ bright cells were signiﬁcant higher at PND3 (Anova p < 0.0001). This pattern was
reversed at PND5, and remained so until PND14.
Fig. 6. Oct4/GFP expression proﬁle after EE2 perinatal exposure: A) percentage of
Oct4/GFP positive cells (Mann Whitney test p < 0.0048), B) MFIi of Oct4/GFP
positive cells (Mann Whitney test p < 0.0011) and C) proportion of Oct4+ bright cells
out of the Oct4/GFP positive cells (Mann Whitney test p < 0.0067).
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analytical tool.
Oct4 belongs to the Octamer class and, together with Pit and
Unc proteins, deﬁne the POU family of transcription factors [29].
After gastrulation in the embryo, Oct4 expression is conﬁned to the
primordial germ cells [23]. In wild type mice, Oct4 is expressed in
mitotically arrested prospermatogonia until birth, and then is
detected in newborn male mice at PND1 and PND7 in undifferen-
tiated spermatogonia [4]. Transgenic mice expressing a transgene
consisting of GFP under the control of the Oct4 promoter in the
germ cell line were generated by Yoshimizu and colleagues [30].
Expression of Oct4-GFP transgenes reﬂects that of the endogenous
Oct4 gene throughout mouse fetal germline development and
postnatal testis until PND7 [30]. As with wild type mice, at PND1,
the expression of Oct4/GFP was detected in the center of the
testicular tubules and the ﬂuorescent-positive cells represented
primitive spermatogonia, persisting until PND7 [30]. In the present
study, we used Oct4/GFP transgenic mice expressing GFP under the
control of the Oct4 promoter to analyze the male immature germ
cell population development throughout the postnatal period.
Testicular cells were collected and analyzed from PND3 until the
adult stage and allowed us to establish the ontogeny of the germ
line during this period (Fig. 2). Based on the cytometric proﬁles
obtained (Fig. 1), we were able to deﬁne variables to estimate both
the abundance of the population (percentage of Oct4/GFP-
expressing cells) and the expression levels of Oct4/GFP (MFIi of
Oct4/GFP and percentage of Oct4+ bright cells). According to our
results, the highest percentage of positive cells was found on PND7,
after which we observed two subpopulations of animals: a
subgroup with a high percentage of Oct4/GFPpositive cells and
another with a smaller proportion of this population (Fig. 3). In
contrast, the levels of Oct4/GFP showed a different expression
pattern, as we observed a peak on PND3, after which it decreased
and remained low from PND5 onwards (Figs. 4 and 5). Previously,
Shimizu et al. [31] observed that, as testes mature, the percentages
of testicular cells expressing GFP in Oct4-EGFP transgenic mice
gradually decrease from 18.7% at PND3 to 1.2% in adults. Our
present results are different from those reported by Shimizu et al.
when considering the percentage of cells expressing GFP (Figs. 2
and 3), but are in agreement when considering only the percentage
of brighter cells (Fig. 5). Interestingly, these authors reported that
in the testes of 7 and 10-day-old or adult males, the populations of
GFP positive and GFP negative cells were not clearly divided, and
some cells showed weak expression of GFP. Some of the different
conditions used to obtain the testicular cell suspensions can help to
explain the observed differences (pore size of the nylon mesh,ﬁxation of cell suspension, etc). Probably one or more of these
conditions allowed us to distinguish two subpopulations with
different intensity of GFP. In our case, the inclusion of the fraction
with lower intensity would explain the observed differences
between these results and those previously published.
To determine whether reservoir formation of male germ cells in
this animal model is a sensitive endpoint to the estrogenic action,
we evaluated the effects of exposure to EE2, a synthetic estrogen
characterized as an EDC [19]. Analyzing the expression pattern of
Oct4/GFP along the postnatal stage, we selected PND7 to study the
possible effects of EE2 on the differentiation of male germ cells. We
selected PND7 because it was the time of development where we
found the highest percentage of cells to analyze and because, at
that point, the cells have completed the migration from the lumen
of the seminiferous tubule to rest on the basement membrane as
SSCs and spermatogonia [32,33]. Thus, we exposed the animals to
Fig. 7. Immunohistochemical analysis of GFP and Oct4 expression in testes after EE2 perinatal exposure (PND7), showing an increase in the GFP (A versus B) and Oct4 (C versus
D) positivity of spermatogonia population in treated animals (indicated with the arrow). In control testes, the cells expressing Oct4 are seen to be distributed exclusively at the
periphery of the seminiferous epithelium, whereas in multiple sections of EE2-treated animals Oct4-expressing cells were located closer to the lumen of the seminiferous
tubule. Magniﬁcation 600.
Fig. 8. Effect of perinatal exposure to EE2 in adult male mice. (A) Sperm motility: Progressive motility (PR); Non-progressive motility (NP); Immotility (IM);(B) Sperm
viability; (C) Sperm count. Signiﬁcant differences were observed in the number of spermatozoa/epididymis in adult male mice treated early in life with EE2 (Mann Whitney
test p < 0.03).
V. Porro et al. / Journal of Steroid Biochemistry & Molecular Biology 154 (2015) 53–61 59
60 V. Porro et al. / Journal of Steroid Biochemistry & Molecular Biology 154 (2015) 53–61EE2 from dpc 5.5 to PND7 in a dose which has been indicated as
appropriate for a positive control of orally administered estrogenic
EDCs [25,26]. We found that EE2 altered the differentiation pattern
of germ cells on PND7 (Fig. 6), as evidenced by an increase in both
the percentage of Oct4/GFP-expressing cells and the levels of
expression of Oct4/GPF (increased MFIi and percentage of brighter
cells). These ﬁndings indicate that formation of germ cells within
the testis is perturbed by exposure to EE2 during a period that has
been characterized as a window of sensitivity to germ cell cancer
(GCC) formation. This relates to the initial maturation of gonocytes
to prespermatogonia. In this period, subtle changes might lead to a
blockade in maturation of gonocytes, which has been postulated as
the earliest pathogenic step in GCC formation [34]. The presence of
Oct4 protein has been related to pluripotent capacity of germ cell
tumors [35] and has been identiﬁed as one of the main diagnostic
markers on tissue sections for the earliest developmental stages of
GCC pathogenesis [34]. In addition, many studies have shown that
gonocyte proliferation/survival just prior to SSC development is
hormone-dependent [33]. In fact, there is a growing body of
evidence indicating that estrogens play an important role in the
proliferation, differentiation and development of male germ cells
[10] and, speciﬁcally, a role for estrogen in spermatogonial division
[12,13,36,37]. Given that gonocytes and differentiating spermato-
gonia during the early neonatal period have been shown to contain
ERb, a direct action of estrogen on germ cells is entirely possible
[38,39]. Interestingly, a link between estrogenic disruption and
germ cell anomalies has been established, evidenced by ﬁndings of
germ cell sloughing, disruption of blood–testis barrier and germ
cell apoptosis provoked by exposure to some environmental
xenoestrogens [20]. However, it is difﬁcult to conclude whether
this effect is direct, or via perturbation of the signals from the
cellular microenvironment [10,33].
To conﬁrm whether the increase in Oct4/GFP in response to EE2
observed in ﬂow cytometry is reﬂected histologically, we analyzed
the expression of GFP and endogenous Oct4 in seminiferous
tubules by immunohistochemistry. We observed that expression of
both proteins GFP and Oct4 was higher in the seminiferous tubules
of the animals that were exposed to EE2 when compared with
controls (Fig. 7). We also detected this increase in the levels of
endogenous Oct4 by RT-PCR when the GFP-positive cells from the
testes of control and EE2-treated pups were isolated by cell sorting
(unpublished data). In 2000, Niwa and coworkers established that
the amount of Oct4 is critical in the control of cell pluripotency,
acting as a master regulator that controls lineage commitment [6].
Recently, to gain insight into the mechanisms by which some
xenoestrogens could modulate stem cell function, Yang et al.
demonstrated that exposure to the xenoestrogenbisphenol A (BPA)
up-regulates the expression of the transcription factors required
for maintaining stem cell pluripotency and self-renewal, including
Oct4, in a dose dependent manner [40]. Based on these and other
results, it has been suggested that BPA disrupts differentiation by
promoting a stem cell phenotype [27]. Herein, we found increased
Oct4 protein expression on PND7 by exposure to EE2. As
mentioned earlier, Oct4 is part of the spectrum of diagnostic
markers suitable for application in a clinical setting of human germ
cell tumors [34]. Moreover, recent evidence suggests that upon
speciﬁc phosphorylation, Oct4 protein interacts more dominantly
with the pluripotency markers SOX2 and NANOG, and this would
be related to an induction of pluripotency [41]. The changes
simultaneously observed using ﬂow cytometry and histology
indicate that estrogen may be able to modify the stemness state in
germ cells.
The changes we observed in early life by ﬂow cytometry and
histology in response to EE2 were conﬁrmed by a reduction in
epididymal sperm count in adult mice. These results agree with the
data reported by others authors, in which sperm production isreduced in male rodent offspring both perinatally or prenatally
exposed to EE2 [42,43].The World Health Organization (WHO) and
the United Nations Environment Programme (UNEP) have reported
in their last update about EDCs that semen quality has declined and
sperm counts are in the subfertile range in several countries (16).
However, the question of declining sperm counts continues to
cause controversy, even today [44,45]. Present data add evidence
to the hypothesis of EDCs as a cause of reduced sperm quality
worldwide.
Our results support the use of the Oct4/GFP transgenic mouse as
a tool to study the impact of environmental estrogens in the
differentiation of male germ cells. Moreover, the model would be
useful to detect alteration early in life, which can interfere with
adult reproduction. As has been recently emphasized, our results
suggest that estrogen may affect the spermatogonial stem cell pool
of the developing testis [46]. On the other hand, ﬂow cytometry
has proved to be an appropriate tool to identify immature male
germ cells populations in a fast and robust quantitative manner
and with high statistical value. In addition, ﬂow cytometry offers
the possibility to perform cell sorting to work with pure
populations of germ cells. Our results suggest that the transgenic
Oct4/GFP mouse together with ﬂow cytometry could be used to
identify early life exposures to EDCs.
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